BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12775136)

  • 1. "Real-world" effectiveness of daily controller medicine in children with mild persistent asthma.
    Bukstein DA; Luskin AT; Bernstein A
    Ann Allergy Asthma Immunol; 2003 May; 90(5):543-9. PubMed ID: 12775136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
    Garcia Garcia ML; Wahn U; Gilles L; Swern A; Tozzi CA; Polos P
    Pediatrics; 2005 Aug; 116(2):360-9. PubMed ID: 16061590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
    Allen-Ramey FC; Duong PT; Riedel AA; Markson LE; Weiss KB
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of asthma-related health care resource use in children treated with montelukast or fluticasone.
    Allen-Ramey FC; Markson LE; Riedel AA; Sajjan S; Weiss KB
    Curr Med Res Opin; 2006 Aug; 22(8):1453-61. PubMed ID: 16870071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
    J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to asthma controller medication regimens.
    Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW; Stempel DA; Meyer J; Stanford RH; Carranza Rosenzweig JR
    J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
    Zeiger RS; Bird SR; Kaplan MS; Schatz M; Pearlman DS; Orav EJ; Hustad CM; Edelman JM
    Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
    Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
    Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
    Zeiger RS; Szefler SJ; Phillips BR; Schatz M; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM;
    J Allergy Clin Immunol; 2006 Jan; 117(1):45-52. PubMed ID: 16387583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
    Maspero JF; DueƱas-Meza E; Volovitz B; Pinacho Daza C; Kosa L; Vrijens F; Leff JA
    Curr Med Res Opin; 2001; 17(2):96-104. PubMed ID: 11759189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can montelukast shorten prednisolone therapy in children with mild to moderate acute asthma? A randomized controlled trial.
    Schuh S; Willan AR; Stephens D; Dick PT; Coates A
    J Pediatr; 2009 Dec; 155(6):795-800. PubMed ID: 19656525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
    Sorkness CA; Lemanske RF; Mauger DT; Boehmer SJ; Chinchilli VM; Martinez FD; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bloomberg GR; Covar RA; Guilbert TW; Heldt G; Larsen G; Mellon MH; Morgan WJ; Moss MH; Spahn JD; Taussig LM;
    J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.